Kim Askew to Myocardial Infarction
This is a "connection" page, showing publications Kim Askew has written about Myocardial Infarction.
Connection Strength
0.440
-
Stopyra JP, Riley RF, Hiestand BC, Russell GB, Hoekstra JW, Lefebvre CW, Nicks BA, Cline DM, Askew KL, Elliott SB, Herrington DM, Burke GL, Miller CD, Mahler SA. The HEART Pathway Randomized Controlled Trial One-year Outcomes. Acad Emerg Med. 2019 01; 26(1):41-50.
Score: 0.115
-
Stopyra JP, Miller CD, Hiestand BC, Lefebvre CW, Nicks BA, Cline DM, Askew KL, Riley RF, Russell GB, Hoekstra JW, Mahler SA. Validation of the No Objective Testing Rule and Comparison to the HEART Pathway. Acad Emerg Med. 2017 09; 24(9):1165-1168.
Score: 0.108
-
Mahler SA, Stopyra JP, Apple FS, Riley RF, Russell GB, Hiestand BC, Hoekstra JW, Lefebvre CW, Nicks BA, Cline DM, Askew KL, Herrington DM, Burke GL, Miller CD. Use of the HEART Pathway with high sensitivity cardiac troponins: A secondary analysis. Clin Biochem. 2017 May; 50(7-8):401-407.
Score: 0.104
-
Stopyra JP, Miller CD, Hiestand BC, Lefebvre CW, Nicks BA, Cline DM, Askew KL, Riley RF, Russell GB, Hoekstra JW, Mahler SA. Performance of the EDACS-accelerated Diagnostic Pathway in a Cohort of US Patients with Acute Chest Pain. Crit Pathw Cardiol. 2015 Dec; 14(4):134-8.
Score: 0.096
-
Miller CD, Litt HI, Askew K, Entrikin D, Carr JJ, Chang AM, Kilkenny J, Weisenthal B, Hollander JE. Implications of 25% to 50% coronary stenosis with cardiac computed tomographic angiography in ED patients. Am J Emerg Med. 2012 May; 30(4):597-605.
Score: 0.017